Hence, the search for new HDAC inhibitors with improved activities has become a relevant and prospering field of anticancer research and several HDAC inhibitors with promising effects on prostate cancer and liver cancer were recently described [4,5,6,7,8]. Here, HDAC9 is linked to prostate carcinoma.